DAMAGE TO THE PANCREAS IN INFLAMMATORY BOWEL DISEASES
Abstract
Inflammatory bowel diseases (IBD) are multisystem diseases and often involve the pancreas. Pancreatic pathology in Crohn’s disease and ulcerative colitis occurs, according to a number of sources, more often than in the general population. Pancreatic manifestations in IBD include a broad heterogeneous group of pancreatic disorders and range from asymptomatic to severe disorders. Acute pancreatitis, chronic pancreatitis, autoimmune pancreatitis, exocrine pancreatic insufficiency, asymptomatic developmental abnormalities, and laboratory changes may be present and associated with IBD. Damage to the pancreas in IBD can be a result of the IBD itself or develop as a result of drug therapy.
References
Минина С.Н., Корниенко Е.А., Суспицын Е.Н., Имянитов Е.Н. Течение панкреатита у детей при воспалительных заболеваниях кишечника. Гастроэнтерология Санкт-Петербурга. 2020;1-2:47–48.
Минина С.Н., Корниенко Е.А., Суспицын Е.Н., Имянитов Е.Н. Этиологическая структура, диагностические критерии и принципы лечения панкреатитов у детей. Вопросы детской диетологии. 2020;18(3):54–64.
Bermejo F., Lopez-Sanroman A., Taxonera C., Gisbert J.P., Perez-Calle J.L., Vera I., Menchen L. et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008;28(5):623–628.
Broide E., Dotan I., Weiss B., Wilschanski M., Yerushalmi B., Klar A., Levine A. Idiopathic pancreatitis preceding the diagnosis of inflammatory bowel disease is more frequent in pediatric patients. J Pediatr Gastroenterol Nutr. 2011;52(6):714–717.
Chen Y.T., Su J.S., Tseng C.W., Chen C.C., Lin C.L., Kao C.H. Inflammatory bowel disease on the risk of acute pancreatitis: A population-based cohort study. J Gastroenterol Hepatol. 2016;31(4):782–787.
Chen Y.L., Hsu C.W., Cheng C.C., Yiang G.T., Lin C.S., Lin C.L., Sung F.C. et al. Increased subsequent risk
of inflammatory bowel disease association in patients with chronic pancreatitis: a nationwide population-based cohort study. Curr Med Res Opin. 2017;33(6):1077–1082.
Ledder O., Lemberg D.A., Day A.S. Thiopurine-inducedpancreatitis in inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol. 2015;9(4):399–403.
Lorenzo D., Maire F., Stefanescu C., Gornet J.M., Seksik P., Serrero M., Bournet B. et al. Features of autoimmune pancreatitis associated with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16(1):59–67.
Majumder S., Chari S.T. Chronic pancreatitis. Lancet. 2016;387(10031):1957–1966.
Picardo S., So K., Venugopal K., Chin M. Vedolizumab induced acute pancreatitis: the first reported clinical case.BMJ Case Rep. 2018;2018.
Ramos L.R., Sachar D.B., DiMaio C.J., Colombel J.F., Torres J. Inflammatory bowel disease and pancreatitis: a review. J Crohns Colitis. 2016;10(1):95–104.
Russo L., Schneider G., Gardiner M.H., Lanes S., Streck P., Rosen S. Role of pharmaco epidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients usingmesalazine. Eur J Clin Pharmacol. 2014;70(6):709–717.
Spanier B.W., Dijkgraaf M.G., Bruno M.J. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: an update. Best Pract Res Clin Gastroenterol. 2008;22(1):45–63.
Srinath A.I., Gupta N., Husain S.Z. Probing the association of pancreatitis in inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(2):465–475.
Teich N., Mohl W., Bokemeyer B., Bundgens B., Buning J., Miehlke S., Huppe D. et al. Azathioprine-induced acutepancreatitis in patients with inflammatory bowel diseases — a prospective study on incidence and severity. J Crohns Colitis. 2016;10(1):61–68.
Tsen A., Alishahi Y., Rosenkranz L. Autoimmune pancreatitis and inflammatory bowel disease: an updated review. J Clin Gastroenterol. 2017;51(3):208–214.
Uchida K., Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis. J Gastroenterol. 2018;53(4):475–483.
Ueki T., Kawamoto K., Otsuka Y., Minoda R., Maruo T., Matsumura K., Noma E. et al. Prevalence and clinicopathological features of autoimmune pancreatitis in Japanese patients with inflammatory bowel disease. Pancreas. 2015;44(3):434–440.
Vavricka S.R., Schoepfer A., Scharl M., Lakatos P.L., Navarini A., Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982–1992.
